Acute nociception mediated by hindpaw P2X receptor activation in the rat

British Journal of Pharmacology

Volumn 122, Issue 2, 1997, Pages 365-371

  Bland Ward, P A ^a   Humphrey, P P A ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

, methylene ATP; Hindpaw lifting; P2X purinoceptors; Sensory neurones; Spontaneous nociception; Subplantar

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; BRADYKININ; BUPIVACAINE; CAPSAICIN; FORMALDEHYDE; MORPHINE; PURINE P2X RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DESENSITIZATION; DOSE RESPONSE; HINDLIMB; INTRAVENOUS DRUG ADMINISTRATION; LICKING; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL;

ADENOSINE TRIPHOSPHATE; ANIMALS; BEHAVIOR, ANIMAL; BRADYKININ; HINDLIMB; MALE; PAIN; RATS; RECEPTORS, PURINERGIC P2;

EID: 0030854414     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701371     Document Type: Article

References (35)

1. ABBOTT, F.V., FRANKLIN, K.B.J. & WESTBROOK, R.F. (1995). The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain, 60, 91-102.
2. BEAN, B.P. (1990). ATP-activated channels in rat and bullfrog sensory neurons: concentration dependence and kinetics. J. Neurosci., 10, 1-10.
3. BLEEHEN, T. & KEELE, C.A. (1977). Observations on the algogenic actions of adenosine compounds on the human blister base preparation. Pain, 3, 367-377.
4. BRAKE, A.J., WAGENBACH, M.J. & JULIUS, D. (1994). New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature, 371, 519-523.
5. 2X receptor expressed in epithelia and brain. EMBO J., 15, 55-62.
6. BURNSTOCK, G. (1996). P2 purinoceptors: historical perspective and classification. In P2 Purinoceptors: Localization, Function and Transduction Mechanisms, ed. Chadwick, D.J. & Goode, J.A. pp. 1-28. Chichester, U.K.: John Wiley & Sons Ltd.
7. 2-purinoceptor? Gen. Pharmacol., 16, 433-440.
8. BURNSTOCK, G. & WOOD, J.N. (1996). Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr. Opinion Neurobiol., 6, 526-532.
9. CHEN, C.-C., AKOPIAN, A.N., SIVILOTTI, L., COLQUHOUN, D., BURNSTOCK, G. & WOOD, J.N. (1995). A P2X purinoceptor expressed by a subset of sensory neurones. Nature, 377, 428-431.
10. CODERRE, T.J., FUNDYTUS, M.E., MCKENNA, J.E., DALAL, S. & MELZACK, M. (1993). The formalin test: a validation of the weighted-scores method of behavioural pain rating. Pain, 54, 43-50.
11. 6 receptors and the distribution and properties of an extended family of ATP-Gated ion channels. J. Neurosci., 16, 2495-2507.
12. COUTTS, A.A., JORIZZO, J.L., EADY, R.A.J., GREAVES, M.W. & BURNSTOCK, G. (1981). Adenosine triphosphate-evoked vascular changes in human skin: mechanism of action. Eur. J. Pharmacol., 76, 391-401.
13. 2-purinoceptor antagonists in rats. Brain Res., 666, 182-188.
14. DUBUISSON, D. & DENNIS, S.G. (1977). The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain, 4, 161-174.
15. 2X Purinoceptors). Mol. Pharmacol., 48, 178-183.
16. FYFFE, R.E.W. & PERL, E.R. (1984). Is ATP a central synaptic mediator for certain primary afferent fibers from mammalian skin? Proc. Natl. Acad. Sci. U.S.A., 81, 6890-6893.
17. HO, B.T., HUO, Y.Y., LU, J.G., NEWMAN, R.A. & LEVIN, V.A. (1992). Analgesic activity of anticancer agent suramin. Anti-Cancer Drugs, 3, 91-94.
18. HONG, Y. & ABBOTT, F.V. (1994). Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience, 63, 827-836.
19. 2X purinoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 585-596.
20. JAHR, C.E. & JESSELL, T.M. (1983). ATP excites a subpopulation of rat dorsal horn neurones. Nature, 304, 730-733.
21. KENNEDY, C., WESTFALL, T.D. & SNEDDON, P. (1996). Modulation of purinergic neurotransmission by ecto-ATPase. Seminars Neurosci., 8, 195-199.
22. KENNEDY, C. & LEFF, P. (1995). Painful connection for ATP. Nature, 377, 385-386.
23. 2X-purinoceptors in rat superior cervical, nodose and guinea-pig coeliac neurones. J. Physiol., 484, 385-395.
24. 2X purinoceptor transcripts in the rat nervous system. Mol. Pharmacol., 48, 569-573.
25. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature, 377, 432-435.
26. MANNING, D.C., RAJA, S.N., MEYER, R.A. & CAMPBELL, J.N. (1991). Pain and hyperalgesia after intradermal injection of bradykinin in humans. Clin. Pharmacol. Ther., 50, 721-729.
27. NORTH, R.A. (1996). P2X purinoceptor plethora. Seminars Neurosci., 8, 187-194.
28. PARSONS, C.G. & HEADLEY, P.M. (1989). Spinal antinociceptive actions of μ- and κ-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus. Br. J. Pharmacol., 98, 523-532.
29. 2X-purinoceptor in cultured neurones of the rat dorsal root ganglia. Br. J. Pharmacol., 118, 951-956.
30. SALTER, M.W. & HENRY, J.L. (1985). Effects of adenosine 5′-monophosphate and adenosine 5′-triphosphate on functionally identified units in the cat spinal dorsal horn. Evidence for a differential effect of adenosine 5′-triphosphate on nociceptive vs non-nociceptive units. Neuroscience, 15, 815-825.
31. 2X Receptor (P2X7). Science, 272, 735-738.
32. TREZISE, D.J. & HUMPHREY, P.P.A. (1997). Activation of cutaneous afferent neurones by ATP. In Experimental Headache Models, Frontiers in Headache Research, Vol. 6. ed. Olesen J. & Moskowitz, M.A. pp. 111-116. New York: Raven Press.
33. 2X receptor for extracellular ATP. Nature, 371, 516-519.
34. WANG, C.-Z., NAMBA, N., GONOI, T., INAGAKI, N. & SEINO, S. (1996). Cloning and pharmacological characterization of a fourth P2X receptor subtype widely expressed in brain and peripheral tissues including various endocrine tissues. Biochem. Biophys. Res. Commun., 220, 196-202.
35. ZIGANSHINA, L.E., ZIGANSHIN, A.U., HOYLE, C.H.V. & BURNSTOCK, G. (1996). Acute paw oedema formation induced by ATP: Re-evaluation of the mechanisms involved. Inflamm. Res., 45, 96-102.